109 related articles for article (PubMed ID: 34871815)
1. Lipopeptides against COVID-19 RNA-dependent RNA polymerase using molecular docking.
Xia B; Luo M; Pang L; Liu X; Yi Y
Biomed J; 2021 Dec; 44(6 Suppl 1):S15-S24. PubMed ID: 34871815
[TBL] [Abstract][Full Text] [Related]
2. Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses.
Elkarhat Z; Charoute H; Elkhattabi L; Barakat A; Rouba H
J Biomol Struct Dyn; 2022 Jan; 40(1):361-374. PubMed ID: 32873176
[TBL] [Abstract][Full Text] [Related]
3. Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against
Naidu SAG; Mustafa G; Clemens RA; Naidu AS
J Diet Suppl; 2023; 20(2):254-283. PubMed ID: 34850656
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).
Ruan Z; Liu C; Guo Y; He Z; Huang X; Jia X; Yang T
J Med Virol; 2021 Jan; 93(1):389-400. PubMed ID: 32579254
[TBL] [Abstract][Full Text] [Related]
5. In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.
Mondal SK; Mukhoty S; Kundu H; Ghosh S; Sen MK; Das S; Brogi S
Comput Biol Med; 2021 Aug; 135():104591. PubMed ID: 34216889
[TBL] [Abstract][Full Text] [Related]
6. Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an
Mutlu O; Ugurel OM; Sariyer E; Ata O; Inci TG; Ugurel E; Kocer S; Turgut-Balik D
J Biomol Struct Dyn; 2022 Feb; 40(2):918-930. PubMed ID: 32933378
[TBL] [Abstract][Full Text] [Related]
7. Molecular modelling and structure-activity relationship of a natural derivative of
Ayipo YO; Ahmad I; Najib YS; Sheu SK; Patel H; Mordi MN
J Biomol Struct Dyn; 2023 Mar; 41(5):1959-1977. PubMed ID: 35037841
[TBL] [Abstract][Full Text] [Related]
8. Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 virus.
Narayanan N; Nair DT
IUBMB Life; 2020 Oct; 72(10):2112-2120. PubMed ID: 32812340
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
Zhang L; Zhou R
J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
[TBL] [Abstract][Full Text] [Related]
10. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
[TBL] [Abstract][Full Text] [Related]
11. Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach.
Singh SK; Upadhyay AK; Reddy MS
3 Biotech; 2021 Feb; 11(2):93. PubMed ID: 33520579
[TBL] [Abstract][Full Text] [Related]
12. Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2.
Dey SK; Saini M; Dhembla C; Bhatt S; Rajesh AS; Anand V; Das HK; Kundu S
J Biomol Struct Dyn; 2022; 40(24):14067-14083. PubMed ID: 34784490
[TBL] [Abstract][Full Text] [Related]
13. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2.
Machitani M; Takei J; Kaneko MK; Ueki S; Ohashi H; Watashi K; Kato Y; Masutomi K
Virol J; 2022 Dec; 19(1):213. PubMed ID: 36496472
[TBL] [Abstract][Full Text] [Related]
14. Structure of the RNA-dependent RNA polymerase from COVID-19 virus.
Gao Y; Yan L; Huang Y; Liu F; Zhao Y; Cao L; Wang T; Sun Q; Ming Z; Zhang L; Ge J; Zheng L; Zhang Y; Wang H; Zhu Y; Zhu C; Hu T; Hua T; Zhang B; Yang X; Li J; Yang H; Liu Z; Xu W; Guddat LW; Wang Q; Lou Z; Rao Z
Science; 2020 May; 368(6492):779-782. PubMed ID: 32277040
[TBL] [Abstract][Full Text] [Related]
15. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
16. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.
Wang Q; Wu J; Wang H; Gao Y; Liu Q; Mu A; Ji W; Yan L; Zhu Y; Zhu C; Fang X; Yang X; Huang Y; Gao H; Liu F; Ge J; Sun Q; Yang X; Xu W; Liu Z; Yang H; Lou Z; Jiang B; Guddat LW; Gong P; Rao Z
Cell; 2020 Jul; 182(2):417-428.e13. PubMed ID: 32526208
[TBL] [Abstract][Full Text] [Related]
17. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus.
Tiwari V
Int J Biol Macromol; 2021 Feb; 171():358-365. PubMed ID: 33421473
[TBL] [Abstract][Full Text] [Related]
18. In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV.
Udofia IA; Gbayo KO; Oloba-Whenu OA; Ogunbayo TB; Isanbor C
Netw Model Anal Health Inform Bioinform; 2021; 10(1):22. PubMed ID: 33786291
[TBL] [Abstract][Full Text] [Related]
19. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19.
Rabie AM
Curr Res Pharmacol Drug Discov; 2021; 2():100055. PubMed ID: 34870153
[TBL] [Abstract][Full Text] [Related]
20. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
